Publications (128) Publications in which a researcher has participated

filter_list Internal Medicine

2025

  1. Corrigendum to “Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia” [Kidney International Reports Volume 9, Issue 5, May 2024, Pages 1419-1428] (Kidney International Reports (2024) 9(5) (1419–1428), (S2468024924014931), (10.1016/j.ekir.2024.02.1403)

    Kidney International Reports

2024

  1. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population

    Nefrologia, Vol. 44, Núm. 1, pp. 77-89

  2. Impact and consequences of the error of estimated GFR in patients with heart failure

    Scientific Reports, Vol. 14, Núm. 1

  3. Induction of diabetes by Tacrolimus in a phenotypic model of obesity and metabolic syndrome

    Frontiers in Endocrinology, Vol. 15

  4. Measured and Estimated Glomerular Filtration Rate to Evaluate Rapid Progression and Changes over Time in Autosomal Polycystic Kidney Disease: Potential Impact on Therapeutic Decision-Making

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

  5. Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1

    Kidney International Reports, Vol. 9, Núm. 1, pp. 114-133

  6. Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia

    Kidney International Reports, Vol. 9, Núm. 5, pp. 1419-1428

2023

  1. Association between Cardiovascular Health, C-Reactive Protein, and Comorbidities in Spanish Urban-Dwelling Overweight/Obese Hypertensive Patients

    Journal of Cardiovascular Development and Disease, Vol. 10, Núm. 7

  2. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population

    Nefrologia

  3. The Role of Gender Differences and Menopause in Obesity-Related Renal Disease, Renal Inflammation and Lipotoxicity

    International journal of molecular sciences, Vol. 24, Núm. 16

2022

  1. Cardio-renal benefits of sacubitril/valsartan in patients with advanced chronic kidney disease: experience in daily clinical practice

    BMC Nephrology, Vol. 23, Núm. 1

  2. Different phenotypic outcome due to site-specific phosphorylation in the cancer-associated NQO1 enzyme studied by phosphomimetic mutations

    Archives of Biochemistry and Biophysics, Vol. 729

  3. Gastric metastases with a choriocarcinoma component from a postpuberal teratoma with mature histology

    Revista Espanola de Patologia, Vol. 55, pp. S49-S53

  4. Molecular diagnosis in non-small-cell lung cancer: Expert opinion on ALK and ROS1 testing

    Journal of Clinical Pathology, Vol. 75, Núm. 3, pp. 145-153

  5. Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 6, pp. 1125-1131

  6. Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1

    Journal of Personalized Medicine, Vol. 12, Núm. 5

2021

  1. ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

    Oncogene, Vol. 40, Núm. 16, pp. 2923-2935

  2. Decrease in cd14++cd16+ monocytes in low-immunological-risk kidney transplant patients with subclinical borderline inflammation

    Journal of Clinical Medicine, Vol. 10, Núm. 21

  3. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation

    Transplant International, Vol. 34, Núm. 8, pp. 1341-1359

  4. Hemodialysis Centers Guide 2020

    Nefrologia, Vol. 41, pp. 1-77